
InVivo NSA raises €215m from Eurazeo et al.
French animal feed and nutrition company InVivo NSA has secured €215m from Eurazeo and CDC International Capital alongside existing investors Unigrains and IDIA Crédit Agricole.
Eurazeo, which contributed €114m to the round, secured a 17.3% stake. Meanwhile, parent company InVivo Group retained a 67% stake to remain majority shareholder.
This capital increase took place after Eurazeo entered exclusive discussions to acquire a minority stake in InVivo NSA in February.
The funding round is part of InVivo NSA's 10-year strategy to expand across emerging markets worldwide via targeted acquisitions. Previous purchases include additives company Pancosma in September 2014 and Brazilian pet food business Total Alimentos in October 2014.
The food producer intends to use the fresh funds and additional borrowing to deploy between €400m-€500m in the next three years.
Company
Founded in 1963, InVivo NSA is an animal feed and nutrition company providing services related to complete feed, feed additives, analysis laboratories and animal health. Headquartered in Saint Nolff, France, it has a workforce of 6,830 across 72 production sites in 28 countries. The company recently reported €1.5bn in revenues.
People
Eurazeo was represented by managing director Frans Tieleman. Thierry Blandinières is CEO at InVivo Group and Hubert de Roquefeuil holds the same position at InVivo NSA.
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote
Permira to take Ergomed private for GBP 703m
Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO
Partners Group to release IMs for Civica sale in mid-September
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Change of mind: Sponsors take to de-listing their own assets
EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater